Market revenue in 2023 | USD 81.4 million |
Market revenue in 2030 | USD 115.4 million |
Growth rate | 5.1% (CAGR from 2023 to 2030) |
Largest segment | Inactivated (killed) |
Fastest growing segment | Other Vaccines (e.g. Recombinant, DNA, subunit, or toxoids) |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Modified/ Attenuated Live, Inactivated (Killed), Other Vaccines (e.g. Recombinant, DNA, subunit, or toxoids) |
Key market players worldwide | Merck & Co Inc, CEVA Inc, Zoetis, Boehringer Ingelheim, Elanco Animal Health Inc, Indian Immunologicals, Biogenesis Bago, Phibro Animal Health Corp Class A, Virbac SA |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to swine vaccines market will help companies and investors design strategic landscapes.
Inactivated (killed) was the largest segment with a revenue share of 37.84% in 2023. Horizon Databook has segmented the India swine vaccines market based on modified/ attenuated live, inactivated (killed), other vaccines (e.g. recombinant, dna, subunit, or toxoids) covering the revenue growth of each sub-segment from 2018 to 2030.
Increasing prevalence of livestock animal diseases, such as coccidiosis, rabies, and swine pneumonia, in this country is likely to drive market growth. The sector is also growing as a result of increased government initiatives.
One of the most recent government efforts was the introduction of the National Animal Disease Control Program, which would cost around USD 1.8 billion (INR 13,343 crore). The program's only goal is to fully vaccinate 530 million animals throughout the country, including pigs, buffalos, and sheep, among others, and eliminate livestock infections by FY 2030.
Furthermore, key developments, such as acquisitions, partnerships, product launches, and business developments are expected to drive the market. For instance, in April 2021, Ahmedabad-based Hester Bioscience was granted an exclusive license to manufacture classical swine fever and sheep pox vaccines in India.
Horizon Databook provides a detailed overview of country-level data and insights on the India swine vaccines market , including forecasts for subscribers. This country databook contains high-level insights into India swine vaccines market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account